GlassScriptPhysician profile
Kishor N Vora
NPI 1992753727
$21,233.42
in general payments reported to CMS, 2019-2025
53 companies · $586 in 2025
The $586 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $493 · 2021: $1,342 · 2022: $576 · 2023: $477 · 2024: $1,992 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,785 · Travel and Lodging: $1,170 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,785.39 |
| Travel and Lodging | $1,169.68 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $11,525.75 | 2019-2024 | |
| Abbott Laboratories | $1,889.60 | 2019-2025 | Jeti, Diamondback Peripheral, Diamondback Coronary |
| Biotronik INC. | $1,576.23 | 2019-2024 | Selectra, Solia, Biomonitor |
| Penumbra, INC. | $1,168.44 | 2019 | |
| Medtronic, INC. | $718.70 | 2021-2022 | |
| Avinger INC. | $672.19 | 2019 | |
| Cardiovascular Systems INC. | $671.58 | 2019-2022 | |
| Boston Scientific Corporation | $435.12 | 2019-2025 | Varithena Administration Pack, Baylis Medical Company Radiofrequency Puncture Generator, Rotapro |
| Canon Medical Systems USA, INC. | $305.00 | 2021 | |
| Abiomed | $254.42 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $234.68 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $192.50 | 2019-2023 | Andexxa, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $164.51 | 2019-2025 | Camzyos, Eliquis |
| Angiodynamics, INC. | $147.68 | 2021-2025 | Auryon Laser System 100-120 Vac |
| Amgen INC. | $138.00 | 2019-2025 | Repatha, Repatha |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $124.57 | 2023-2024 | Inpefa |
| Bard Peripheral Vascular, INC. | $115.23 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Alnylam Pharmaceuticals INC. | $103.32 | 2024-2025 | Onpattro, Amvuttra |
| Philips North America LLC | $100.46 | 2019-2022 | |
| Elutia, INC. | $88.51 | 2019-2023 | |
| Cardinal Health 200 LLC | $85.48 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $55.42 | 2021-2025 | Verquvo |
| Pfizer INC. | $40.25 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $36.14 | 2019-2020 | |
| Thrombolex, INC. | $35.74 | 2025 | Bashir Endovascular Catheter |
| Cvrx, INC. | $31.68 | 2022 | |
| Edwards Lifesciences Corporation | $29.49 | 2025 | Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $28.21 | 2024-2025 | |
| Biocompatibles, INC. | $25.87 | 2019 | |
| Cook Medical LLC | $25.17 | 2019-2020 | |
| Argon Medical Devices, INC. | $19.33 | 2025 | Clot Management |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.79 | 2024 | Jardiance |
| W. L. Gore & Associates, INC. | $18.54 | 2019 | |
| Cagent Vascular INC | $18.04 | 2022 | |
| Ekos Corporation | $16.94 | 2019 | |
| Organogenesis INC. | $15.95 | 2021 | |
| Smith+Nephew, INC. | $15.28 | 2020 | |
| Nevro Corp. | $15.10 | 2024 | Senza |
| Cashflow Solutions, LLC | $14.95 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Inspire Medical Systems, INC. | $14.48 | 2025 | Inspire |
| Amarin Pharma, INC. | $14.06 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.62 | 2020 | |
| Apria Healthcare LLC | $12.20 | 2021 | |
| Venclose INC. | $6.20 | 2020 |
9 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kishor Vora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.